OtherClinical Investigations (Human)
Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study.
caroline bodet-milin, Alain faivre-chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, delphine Drui, David M Goldenberg, Robert M Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
Journal of Nuclear Medicine February 2021, jnumed.120.252791; DOI: https://doi.org/10.2967/jnumed.120.252791
caroline bodet-milin
1 Universite de Nantes, CHU Nantes, CNRS, Inserm, CRCINA, France;
Alain faivre-chauvet
2 Universite de Nantes, CHU Nantes, CNRS, Inserm, CRCINA,, France;
Thomas Carlier
2 Universite de Nantes, CHU Nantes, CNRS, Inserm, CRCINA,, France;
Catherine Ansquer
2 Universite de Nantes, CHU Nantes, CNRS, Inserm, CRCINA,, France;
Aurore Rauscher
3 Pharmacy Unit, ICO Cancer Center,, France;
Eric Frampas
4 Radiology department, University Hospital,, France;
frederique Toulgoat
5 Radiology department, University Hospital, France;
Damien Masson
6 Biology, University Hospital, France;
Mickael Bourgeois
1 Universite de Nantes, CHU Nantes, CNRS, Inserm, CRCINA, France;
Evelyne Cerato
7 Délégation à la Recherche Clinique et à l'Innovation, France;
Vincent Rohmer
8 Endocrinology Department, University Hospital, Angers, France, France;
Olivier Couturier
9 Nuclear Medicine, University Hospital, Angers, France, France;
delphine Drui
10 Endocrinology Department, University Hospital, France;
David M Goldenberg
11 Immunomedics, Inc. ; IBC Pharmaceuticals, Inc., United States;
Robert M Sharkey
12 Immunomedics, Inc., United States;
Jacques Barbet
13 GIP Arronax, France
Francoise Kraeber-Bodere
2 Universite de Nantes, CHU Nantes, CNRS, Inserm, CRCINA,, France;
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study.
caroline bodet-milin, Alain faivre-chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, delphine Drui, David M Goldenberg, Robert M Sharkey, Jacques Barbet, Francoise Kraeber-Bodere
Journal of Nuclear Medicine Feb 2021, jnumed.120.252791; DOI: 10.2967/jnumed.120.252791
Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study.
caroline bodet-milin, Alain faivre-chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, delphine Drui, David M Goldenberg, Robert M Sharkey, Jacques Barbet, Francoise Kraeber-Bodere
Journal of Nuclear Medicine Feb 2021, jnumed.120.252791; DOI: 10.2967/jnumed.120.252791